BioNexus Gene Lab Corp Common stock

BGLCNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
2.20 USD
↘ 0.10 (4.14%)AT CLOSE (11:59 AM EDT)
2.20
↘ 0.01 (0.23%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
2.20
↘ 0.01 (0.23%)
🟢Market: OPEN
Open?$2.18
High?$2.20
Low?$2.14
Prev. Close?$2.30
Volume?5.4K
Avg. Volume?21.9K
VWAP?$2.20
Rel. Volume?0.25x
Bid / Ask
Bid?$1.84 × 100
Ask?$2.62 × 100
Spread?$0.78
Midpoint?$2.23
Valuation & Ratios
Market Cap?5.6M
Shares Out?2.4M
Float?1.7M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.69
EPS?-$1.20
Dividend?0.00%
Ex-Dividend?N/A

BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $2.20. BGLC shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & Diagnostics
Employees
1
Market Cap
5.5M
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.bionexusgenelab.com
Listed
2020-03-11
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,
KUALA LUMPUR, N8 59200
Phone: 1-307-241-6898
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
95
Momentum?
14
Short Sent.?
59
Piotroski F-Score?1/9Weak
Altman Z-Score?4.40Safe
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.63%Low
Short Interest?10.6K
Days to Cover?2.2
Free Float1.7M
Avg Daily Volume4.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.52Strong
Quick Ratio?5.69Strong
Cash Ratio?1.68Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.69CHEAP▾
P/S?
Peers
100
S&P
86
1.05CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
Peers
100
S&P
94
0.81CHEAP▾
Returns & Efficiency
ROE?
S&P
5
-35.9%WEAK▾
ROA?
S&P
3
-32.1%WEAK▾
Cash Flow & Enterprise
FCF?$-1190225
Enterprise Value?$4.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist